Alexion to Present Key Data on Ultomiris and Soliris for gMG at AANEM and MGFA 2024
Alexion, AstraZeneca Rare Disease, will present data from its leading generalised myasthenia gravis (gMG) portfolio at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and… read more.